Actuate Therapeutics (ACTU) Shares Outstanding (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Shares Outstanding (Entity) of $23.2 million for Q4 2025, up 177.63% year-over-year from $8.4 million in Q4 2024, and little changed quarter-over-quarter from $23.2 million in Q3 2025.
Actuate Therapeutics (ACTU) Shares Outstanding (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Shares Outstanding (Entity) for 3 consecutive years, with $23.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 177.63% year-over-year to $23.2 million; the TTM figure through Dec 2025 stood at $23.2 million (up 177.63% YoY), while the FY2025 annual figure was $23.2 million, up 177.63% from the prior year.
- Shares Outstanding (Entity) held at $23.2 million in Q4 2025 per ACTU's latest filing, from $23.2 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $23.2 million in Q4 2025 and bottomed at $1.4 million in Q2 2023.
- Historically, Shares Outstanding (Entity) has averaged $10.3 million across 3 years, with a median of $8.4 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) climbed 10.1% — and 2025, when it jumped 1207.37%.
- Actuate Therapeutics' Shares Outstanding (Entity) stood at $1.4 million in 2023, then jumped by 483.48% to $8.4 million in 2024, then surged by 177.63% to $23.2 million in 2025.
- Business Quant data shows ACTU's Shares Outstanding (Entity) at $23.2 million in Q4 2025, $23.2 million in Q3 2025, and $20.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | 23.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.02 Mn |
| Sep 30, 2025 | 21.39 Mn |
| Jun 30, 2025 | 19.65 Mn |
| Mar 31, 2025 | 19.50 Mn |
| Dec 31, 2024 | 8.37 Mn |
| Sep 30, 2024 | 10.77 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.43 Mn |
| Sep 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.42 Mn |